Unlimited Access. Try it Today! Your First 10 Days Always $0.99

Topics

UBS AG
FDA approves new type of heart failure drug from Amgen

Patients with chronic heart failure, a disabling, deadly disease that worsens as the heart gradually pumps less efficiently, are getting a much-needed new option with U.S. approval Wednesday of a novel drug from Amgen Inc. Corlanor is the first medication in a dozen years for heart failure, which is becoming more common with obesity — and more people surviving heart attacks due to better treatments. Meanwhile, the Food and Drug Administration is reviewing another heart failure pill, from Novartis AG, and could approve it this summer. More than 5 million Americans and more than 25 million people worldwide have heart failure, which kills up to half of patients within five years,...

Loading

70°